India Presses Russia To Ease Lengthy, Costly Drug-Registration Process
This article was originally published in PharmAsia News
Executive Summary
India is pressing Russia to relax its process for registering foreign-made generics and other drugs, blamed for the nation's meager share of Russia's growing pharmaceutical market.